Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-Associated Steatotic Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06487325
What this trial is testing

A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Fatty Liver Disease
Ma Zhe 120
Not applicableActive Not RecruitingNCT06735924
What this trial is testing

Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis

Who this might be right for
MASLDMetabolic Dysfunction-Associated Steatotic Liver Disease
University of Alabama at Birmingham 28
Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Testing effectiveness (Phase 2)Study completedNCT03938246
What this trial is testing

Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Sagimet Biosciences Inc. 142
Not applicableLooking for participantsNCT06706856
What this trial is testing

Quantitative Ultrasound to Assess Steatotic Liver Disease in Children

Who this might be right for
MASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University of California, San Diego 120
Not applicableStudy completedNCT07211113
What this trial is testing

Effects of Long-lasting Bicarbonate-Sulfate-Calcium-Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcome

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
University of Campania Luigi Vanvitelli 87
Not applicableLooking for participantsNCT07246421
What this trial is testing

Glucagon Resistance in Patients With MASLD and T2DM

Who this might be right for
Metabolic Associated Fatty Liver DiseaseType 2 Diabetes (T2DM)
University of Aarhus 24
Not applicableStudy completedNCT06491342
What this trial is testing

Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver, Nonalcoholic
Phramongkutklao College of Medicine and Hospital 90
Not applicableLooking for participantsNCT07390422
What this trial is testing

Duodenal pulsENDO for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Syndrome (MetS)
Chinese University of Hong Kong 40
Not applicableStudy completedNCT07763626
What this trial is testing

Gdue Plus a Hypocaloric Mediterranean Diet in Adults With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Syndrome
University of Genova 112
Not applicableStudy completedNCT06493253
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,519
Not applicableNot Yet RecruitingNCT07082751
What this trial is testing

Prognostic Model for MASLD Related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseCompensated Cirrhosis
Beijing Friendship Hospital 228
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07313787
What this trial is testing

Effects of Meal Macronutrients on Postprandial Lipids

Who this might be right for
Nephrotic SyndromeLipodystrophyMetabolic Syndrome+3 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100
Not applicableNot Yet RecruitingNCT07684248
What this trial is testing

Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Type 1 Diabetes
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT06920316
What this trial is testing

Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
St. George's Hospital, London 100
Testing effectiveness (Phase 2)Looking for participantsNCT07097506
What this trial is testing

Effect of Ketone Esters on Liver Fat Content and Metabolic Function

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseObesityOverweight (BMI > 25)
Washington University School of Medicine 40
Not applicableStudy completedNCT07798518
What this trial is testing

FIB-4 Index, Sleep Apnea Severity, and Nocturnal Hypoxemia

Who this might be right for
Obstructive Sleep Apnea (OSA)Metabolic Dysfunction-Associated Steatotic Liver Disease
Hisar Intercontinental Hospital 373
Not applicableNot Yet RecruitingNCT07216859
What this trial is testing

Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseCirrhosis
Kaiser Permanente 2,000
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Not applicableNot Yet RecruitingNCT07778719
What this trial is testing

Metformin-Dapagliflozin Effects on IGF-1 in Male T2DM With MASLD

Who this might be right for
Type 2 DiabetesMetabolic Dysfunction-Associated Steatotic Liver Disease
The 95th Hospital of Putian，Putian, Fujian, China 84
Next Page